期刊文献+

^(99m)Tc-美罗华用于原发性乳腺癌前哨淋巴结活检 被引量:7

Sentinel lymph node biopsy with a novel sentinel lymphoscintigraphy agent ^(99m)Tc-Rituximab for breast cancer
下载PDF
导出
摘要 目的分析99mTc-美罗华作为示踪剂对102例原发性乳腺癌(其中1例为双乳癌)患者行前哨淋巴结(SLN)显像及活检的诊断效能。方法超声引导下于乳腺肿块周围及肿块表面皮下注射99mTc-美罗华后行SLN显像,并将采集到的图像与患者数码局部大体像进行图像融合。术中凭此融合图像行腋窝区前哨淋巴结活检术(SLNB)。切除SLN后,行常规乳腺癌手术及腋下淋巴结清扫术,并送病理行常规HE染色及免疫组化检查。结果103例次SLN显像成功率100%,共显示SLN177枚,分布于腋窝区、内乳区及乳腺组织内,平均1.72枚(177/103)。腋窝区SLNB成功率99.03%(102/103),共探测到SLN266枚,平均2.58枚(266/103)。病理发现腋窝SLN有转移者76例次,转移SLN110枚。与腋清扫淋巴结病理结果比较,SLNB的灵敏度为96.20%(76/79),特异性为100%(24/24),假阴性率为3.80%(3/79),准确率为97.09%(100/103)。结论应用新型SLN示踪剂99mTc-美罗华行乳腺癌SLN显像及活检成功率、灵敏度及准确率高,假阴性率较低,具有临床应用价值。 Objective To study the feasibility and reliability of the sentinel lymph node (SLN) imaging and biopsy with a new imaging agent ^99mTc-Rituximab in 102 breast cancer patients (one suffered bilateral breast cancers). Methods The sentinel lymph node imaging was taken after peritumoral and subdermal injection of ^99mTc-Rituximah guided with ultrasound, and was fused with each digital photo. After the sentinel lymph node biopsy (SLNB), routine surgery of breast and axillary lymph node dissection (ALND) was performed. Fresh SLNs and all axillary nodes were examined by pathology. Results There were total 103 times SLN imaging and SLNB in 102 patients, and the success rate of the SLN imaging was 100%. Total 177 SLNs (the average was 1.72) were showed in the images, which distributed in the axilla, the internal mammary and the breast region. The success rate of SLNB was 99.03%, and total 266 SLNs (the average was 2.58) were identified. Pathological examination showed that there were 76 times of metastatic SLN and the total number of metastatic SLN were 110. The sensitivity, specificity and accuracy of SLNB were 96.20%, 100% and 97.09%, respectively; and the false negative rate of SLNB was 3.80%. Conclusion Using ^99mTc-Rituximab as the imaging agent, the sentinel lymph node imaging and biopsy can obtain high success rate, high sensitivity and accuracy, and low false negative rate, so this novel sentinel lymphoscintigraphy agent will have a good future in clinical practice.
出处 《中国医学影像技术》 CSCD 北大核心 2009年第4期681-684,共4页 Chinese Journal of Medical Imaging Technology
关键词 美罗华 乳腺肿瘤 前哨淋巴结活检 Rituximab Breast neoplasms Sentinel lymph node biopsy
  • 相关文献

参考文献11

二级参考文献38

  • 1梁正路,谭天秩,柴力.淋巴显象剂硫化锑胶体冻干药盒的研制[J].华西医学,1995,10(3):319-322. 被引量:1
  • 2[1]Hilsenbeek S G,Ravdin P M,de Moor C A,et al.Time-dependence of hazard ratios for prognostic factors in primary breast cancer.Breast Cancer Res Treat,1998,52:227-237.
  • 3[2]Krag D,Weaver D,Ashikaga T,et al.The sentinel node in breast cancer:a muhicenter validation study.N Engl J Med,1998,339:941-946.
  • 4[3]McMasters K M,Giuliano A E,Ross M I,et al.Sentinel-lymph-node biopsy for breast cancer:not yet the standard of care.N Ensl J Med,1998,339:990-995.
  • 5[4]Veronesi U,Paganelli G,Viale G,et al.Sentinel lymph node biopsy and axillary dissection in breast cancer:results in a large series.J Nad Cancer Inst.1999,91:368-373.
  • 6[5]Wang Y,Yu J,Wang L,et al.The study of sentinel node biopsy in clinical node negative breast cancer in China.Breast Cancer Res Treat,2004,88:S89-S95.
  • 7[6]Thompson J F,Uren R F,Shaw H M,et al.Location of sentinel lymph nodes in patients with cutaneous melanoma:new itrsights into lymphatic anatomy.J Am Coll Surg,1999,189:195-204.
  • 8[7]McMasters K M,Wong S L,Tuttle T M,et al.Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes.Ann Surg,2000,231:724-731.
  • 9[8]Goyal A,Newcombe B G,Mansel R E,et al.Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer.Ear J Cancer,2005,41:238-243.
  • 10[9]Rousseau C,Classe J M,Campion L,et al.The impact of nonvisualization of sentinel nodes on lymphascintigraphy in breast cancer.Ann surg Oncol,2005,12:533-538.

共引文献31

同被引文献98

引证文献7

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部